These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 31104727)

  • 1. Valuing Health: Evolution, Revolution, Resistance, and Reform.
    Phelps CE; Madhavan G
    Value Health; 2019 May; 22(5):505-510. PubMed ID: 31104727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5].
    Phelps CE; Lakdawalla DN; Basu A; Drummond MF; Towse A; Danzon PM
    Value Health; 2018 Feb; 21(2):146-154. PubMed ID: 29477392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.
    Phelps C; Madhavan G; Rappuoli R; Levin S; Shortliffe E; Colwell R
    Milbank Q; 2016 Mar; 94(1):109-25. PubMed ID: 26994711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].
    Lakdawalla DN; Doshi JA; Garrison LP; Phelps CE; Basu A; Danzon PM
    Value Health; 2018 Feb; 21(2):131-139. PubMed ID: 29477390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidden costs: The ethics of cost-effectiveness analyses for health interventions in resource-limited settings.
    Rutstein SE; Price JT; Rosenberg NE; Rennie SM; Biddle AK; Miller WC
    Glob Public Health; 2017 Oct; 12(10):1269-1281. PubMed ID: 27141969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4].
    Danzon PM; Drummond MF; Towse A; Pauly MV
    Value Health; 2018 Feb; 21(2):140-145. PubMed ID: 29477391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget impact analysis.
    Leelahavarong P
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S65-71. PubMed ID: 24964701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disinvestments in practice: overcoming resistance to change through a sociotechnical approach with local stakeholders.
    Airoldi M
    J Health Polit Policy Law; 2013 Dec; 38(6):1149-71. PubMed ID: 23974471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How have systematic priority setting approaches influenced policy making? A synthesis of the current literature.
    Kapiriri L; Razavi D
    Health Policy; 2017 Sep; 121(9):937-946. PubMed ID: 28734682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing the Clinical Effectiveness of Therapeutics.
    Listl S; Faggion CM
    J Evid Based Dent Pract; 2016 Jun; 16(2):86-9. PubMed ID: 27449834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care input constraints and cost effectiveness analysis decision rules.
    van Baal P; Morton A; Severens JL
    Soc Sci Med; 2018 Mar; 200():59-64. PubMed ID: 29421472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding legitimacy for the role of budget impact in drug reimbursement decisions.
    Niezen MG; de Bont A; Busschbach JJ; Cohen JP; Stolk EA
    Int J Technol Assess Health Care; 2009 Jan; 25(1):49-55. PubMed ID: 19126251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
    Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
    Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future Directions for Cost-effectiveness Analyses in Health and Medicine.
    Neumann PJ; Kim DD; Trikalinos TA; Sculpher MJ; Salomon JA; Prosser LA; Owens DK; Meltzer DO; Kuntz KM; Krahn M; Feeny D; Basu A; Russell LB; Siegel JE; Ganiats TG; Sanders GD
    Med Decis Making; 2018 Oct; 38(7):767-777. PubMed ID: 30248277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.